-+ 0.00%
-+ 0.00%
-+ 0.00%
Should Winmark's Expanded Rawlings Partnership Reshape How Investors View WINA's Circular Economy Strategy?
Share
Listen to the news
  • Winmark Corporation recently announced that it has extended its sustainability-focused partnership with Rawlings Sporting Goods, allowing Play It Again Sports stores across North America to continue buying and selling Rawlings and Easton baseball and softball equipment while promoting reuse and affordability.
  • Since this collaboration began in 2022, Play It Again Sports has purchased more than 1 million pieces of used baseball and softball gear, underlining how the partnership supports both household budgets and equipment lifecycle extension for families and athletes.
  • Next, we will examine how the renewed Rawlings partnership and its focus on affordable, reused equipment shapes Winmark’s broader investment narrative.

Explore 25 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.

What Is Winmark's Investment Narrative?

To own Winmark, you need to believe in a relatively mature, asset-light franchising model that can still compound through disciplined capital allocation and a resilient resale niche. The renewed Rawlings partnership reinforces the sustainability and affordability angle at Play It Again Sports, but on its own it is unlikely to shift near term financial catalysts in a material way, especially given recent modest revenue growth and some pressure on margins and earnings. The more immediate drivers remain franchise health, royalty growth and how the company balances a rich valuation with high dividends and a completed buyback program. At the same time, investors have to stay comfortable with leverage, negative equity and a dividend that is not fully covered by free cash flow, even as management leans into brand partnerships like Rawlings and CCM Hockey to support store traffic and equipment volumes.

However, that generous dividend policy comes with trade offs that investors should not ignore. Winmark's share price has been on the slide but might be up to 12% below fair value. Find out if it's a bargain.

Exploring Other Perspectives

WINA 1-Year Stock Price Chart
WINA 1-Year Stock Price Chart
The Simply Wall St Community’s two fair value estimates for Winmark range widely, from about US$301.56 to US$545, underscoring how differently people see the company’s prospects. When you weigh that spread against issues like leverage, negative equity and slower expected growth, it becomes clear that understanding the risk side of the story is just as important as the upside.

Explore 2 other fair value estimates on Winmark - why the stock might be worth as much as 62% more than the current price!

Reach Your Own Conclusion

Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

Seeking Other Investments?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending